1. Home
  2. NKTR vs JMIA Comparison

NKTR vs JMIA Comparison

Compare NKTR & JMIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • JMIA
  • Stock Information
  • Founded
  • NKTR 1990
  • JMIA 2012
  • Country
  • NKTR United States
  • JMIA Germany
  • Employees
  • NKTR N/A
  • JMIA N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • JMIA Catalog/Specialty Distribution
  • Sector
  • NKTR Health Care
  • JMIA Consumer Discretionary
  • Exchange
  • NKTR Nasdaq
  • JMIA Nasdaq
  • Market Cap
  • NKTR 1.2B
  • JMIA 1.2B
  • IPO Year
  • NKTR 1994
  • JMIA 2019
  • Fundamental
  • Price
  • NKTR $57.96
  • JMIA $11.85
  • Analyst Decision
  • NKTR Strong Buy
  • JMIA Buy
  • Analyst Count
  • NKTR 6
  • JMIA 1
  • Target Price
  • NKTR $91.67
  • JMIA $15.00
  • AVG Volume (30 Days)
  • NKTR 1.2M
  • JMIA 3.7M
  • Earning Date
  • NKTR 11-06-2025
  • JMIA 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • JMIA N/A
  • EPS Growth
  • NKTR N/A
  • JMIA N/A
  • EPS
  • NKTR N/A
  • JMIA N/A
  • Revenue
  • NKTR $74,934,000.00
  • JMIA $164,022,000.00
  • Revenue This Year
  • NKTR N/A
  • JMIA $21.84
  • Revenue Next Year
  • NKTR N/A
  • JMIA $12.09
  • P/E Ratio
  • NKTR N/A
  • JMIA N/A
  • Revenue Growth
  • NKTR N/A
  • JMIA N/A
  • 52 Week Low
  • NKTR $6.48
  • JMIA $1.60
  • 52 Week High
  • NKTR $62.95
  • JMIA $12.70
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 65.18
  • JMIA 64.30
  • Support Level
  • NKTR $57.50
  • JMIA $11.53
  • Resistance Level
  • NKTR $62.82
  • JMIA $12.70
  • Average True Range (ATR)
  • NKTR 3.73
  • JMIA 0.65
  • MACD
  • NKTR -0.77
  • JMIA -0.12
  • Stochastic Oscillator
  • NKTR 56.85
  • JMIA 62.56

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

About JMIA Jumia Technologies AG each representing two

Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.

Share on Social Networks: